• Home
  • Publications
  • Newsroom
  • More
    • Home
    • Publications
    • Newsroom
  • Home
  • Publications
  • Newsroom

Developing medical countermeasures against high priority CBRN threats.

Developing medical countermeasures against high priority CBRN threats.Developing medical countermeasures against high priority CBRN threats.Developing medical countermeasures against high priority CBRN threats.

STrategy and Approach

Drug Rescue and Repositioning

CMTx Biotech is pursuing new therapeutic uses and formations of clinical stage drug candidates

Drug Repurposing

CMTx Biotech is pursuing new therapeutic uses and formulations of drugs already approved for human use

About Us

Science & Technology

Experienced Management

Science & Technology

Host-directed therapeutics (HDT's) are a promising class of treatments that target the hyper-inflammatory and dysregulated immune response to infection, insult, or injury.


HDTs have the advantage of being threat agnostic, and can serve as an adjunctive treatment to current standard of care.

Development Pipeline

Experienced Management

Science & Technology

Our lead drug candidate, incyclinide, has completed IND-enabling studies and has been tested safely in humans in a variety other indications.


CMTx R2 is an inhibitor of the Suppressor of T-cell Signaling (STS) proteins approved for human use internationally.  

CMTx is advancing this candidate for host-directed treatment of infectious diseases.

Experienced Management

Experienced Management

Experienced Management

Our management team is composed of a seasoned group of scientists, business managers, technology commercialization and licensing experts.


Together we have past experience developing, manufacturing, and commercializing a variety of products.

Management Team & founders

Profile

Joseph Scaduto, MS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Co-Founder & Chief Executive Officer

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Scientific Co-Founder

James Keane, BS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

James Keane, BS, MBA

Co-Founder & Chief Operating Officer

JoAnn Wilson, PhD

JoAnn Wilson, PhD

James Keane, BS, MBA

VP Chemistry, Manufacturing and Controls

Janet S Lee, PhD

JoAnn Wilson, PhD

Janet S Lee, PhD

VP, Clinical Research

Sonny Granger

JoAnn Wilson, PhD

Janet S Lee, PhD

Co-Founder & Charcot-Marie-Tooth Disease Patient Advocate

Scientific, Clinical, and Strategic Advisors

Brad Zerler, PhD

Sharon Nachman, MD

Sharon Nachman, MD

Former VP of Research, 

CollaGenex Pharmaceuticals

Sharon Nachman, MD

Sharon Nachman, MD

Sharon Nachman, MD

Associate Dean of Research

Stony Brook University School of Medicine

Andrew Protter

Sharon Nachman, MD

Jay Steinberg, DO

Chief Scientific Officer

Auransa, Inc.

Jay Steinberg, DO

Jay Steinberg, DO

Jay Steinberg, DO

Director of Thoracic Surgery

Jefferson Health New Jersey

Gary Nieman, MS

Jay Steinberg, DO

Gary Nieman, MS

Director, Translational Critical Care Laboratory, SUNY Upstate Medical University

Rober Levy, MD

Jay Steinberg, DO

Gary Nieman, MS

CoFounder

PromptCareMD

Academic Collaborators

Michaela Kollisch-Singule, MD

Michaela Kollisch-Singule, MD

Michaela Kollisch-Singule, MD

Associate Professor, 

Division of Pediatric Surgery

University of Arkansas 

Juntao Luo, PhD

Michaela Kollisch-Singule, MD

Michaela Kollisch-Singule, MD

Professor of Pharmacology

SUNY Upstate Medical University

Livia Veress, MD

Michaela Kollisch-Singule, MD

Nicholas Carpino, PhD

Professor, Pediatrics-Pulmonary Medicine

University of Colorado

Anschutz Medical Campus

Nicholas Carpino, PhD

Nicholas Carpino, PhD

Nicholas Carpino, PhD

Associate Professor

Department of Microbiology and Immunology

Stony Brook University

Jarrod French, PhD

Nicholas Carpino, PhD

Jarrod French, PhD

Professor, Nucleotide Metabolism & Drug Discover

The Hormel Institute

University of Minnesota

Ashley Brown, PhD

Nicholas Carpino, PhD

Jarrod French, PhD

Program Director & Associate Professor

Molecule Genetics and Microbiology

University of Florida, Orlando

Contact Us

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please contact us 

CMTx Biotech, Inc.

Stony Brook, NY

info@cmtxbiotech.com (631) 258-5680

Find Us Online

Policies & Procedures

FCOI

Financial Conflict of Interest Policy

Copyright © 2025 CMTx Biotech, Inc. - All Rights Reserved.

  • Publications
  • Newsroom

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept